Deep venous thrombosis and pulmonary embolism

Clinical Obstetrics and Gynecology

Volumn 39, Issue 1, 1996, Pages 87-100

  Brown, Haywood L ^a,b   Hiett, Adam K ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; HEPARIN CALCIUM; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE SULFATE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

ANTICOAGULANT THERAPY; ANTITHROMBIN III DEFICIENCY; BLEEDING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG SCINTISCANNING; MATERNAL MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PREGNANCY COMPLICATION; PROPHYLAXIS; PROTEIN C DEFICIENCY; SUBCUTANEOUS DRUG ADMINISTRATION; VENA CAVA FILTER;

FEMALE; HUMANS; INCIDENCE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PULMONARY EMBOLISM; THROMBOEMBOLISM;

EID: 0030063029     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199603000-00009     Document Type: Conference Paper

References (70)

1. Koonin LM, Atrash HK, Lawson HW, Smith JC. Maternal mortality surveillance, United States, 1979-1986. MMWR CDC Surveill Summ. 1991;40:1-13.
2. Arthure M. maternal mortality. J Obstet Gynaecol Br Commonw. 1968;75:1309.
3. Kunitz AM, Hughes JM, Grimes DA, et al: Causes of maternal mortality in the USA. Obstet Gynecol. 1985;65:605-610
4. National Institutes of Health Consensus Development Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA. 1986;256:744.
5. Virchow R. Phlogose und Thrombose in Gefass-system. In: Virchow R, ed. Gesamelte Abhandlungen Zur Wissenschaflichen Medecin. Frankfurt: Von Medinger Sohn, 1856:458-636.
6. Brozovic M. Mechanisms of deep vein thrombosis: a review. J R Soc Med 1979;72: 602,
7. Alexander B, Meyers L, Kenny J, Goldstein R, Gurewich J, Grinspoon L. Blood coagulation in pregnancy. N Engl J Med. 1956;254:358-363.
8. Bonnar J, McNicol, Douglas AS. Coagulation and fibrinolytic mechanisms during and after normal childbirth. BMJ. 1970;2:200-203.
9. Nilsson IM, Kullander S. Coagulation and fibrinolytic studies during pregnancy. Acta Obstet Gyne Scan. 1967;46:273-285.
10. Nossel HL, Lanzkowsky P, Levy S, et al. A study of coagulation factor levels in women during labour and in their newborn infants. Thromb Diath Haemorrh. 1966;16:185-197.
11. Weiner CP, Kwaan H, Hauck WW, Duboe FJ, Paul M, Wallemark CB. Fibrin generation in normal pregnancy. Obstet Gynecol. 1984:64:46
12. Morgensen K, Skibsted L, Wadt J, Nissen F. Thrombectomy of acute iliofemoral venous thrombosis during pregnancy. Surg Gynecol Obstet. 1989;169:50-54.
13. Kierkegarrd A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Chir Scand. 1980;146:267-269.
14. Coon WW. Epidemiology of venous thromboembolism. Ann Surg. 1977;186:149-164.
15. Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of venous thrombosis and pulmonary embolism. The Worchester DVT Study. Arch Intern Med. 1991;151:933-938.
16. Letsky EA, deSwiet M. Thromboembolism in pregnancy and its management. Br J Haemat. 1984;57:543-552.
17. Aaro LA, Juergens JL. Thrombophlebitis associated with pregnancy. Am J Obstet Gynecol. 1971;109:1128-1136.
18. Henderson SR, Lund Cj, Creasman WT. Antepartum pulmonary embolism. Am J Obstet Gynecol. 1972;112:476-486.
19. Weiner CP. Diagnosis and Management of Thromboembolic disease during pregnancy. Clin Obstet Gynecol. 1985;28:107-118.
20. Rutherford SE, Phelan JP. Thromboembolic disease in pregnancy. Clin Perinatol. 1988;13:719-739.
21. Moore JG, O'Leary JA, Johnson PM. The changing impact of pulmonary thromboembolism in obstetrics. Am J Obstet Gynecol. 1967;97:507-513.
22. Conrad J, Horellou MJ, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost. 1990;63:319-320.
23. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with Protein C and Protein S Deficiency: a prospective cohort study. Thromb Haemost. 1994;71:441-445
24. Malcinaik E, Wilson JD, Marlar RA. Neonatal purpura fulminana: a genetic disorder related to the absence of protein C in blood. Blood. 1985;65:15-20.
25. Sashara AA, Hyers TM, Cole CM, et al. The urokinase pulmonary embolism trial. New York: American Heart Association, Monograph 39, 1973:60.
26. Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost. 1989;61:189-196.
27. Rutherford SE, Phelan J. Deep venous thrombosis and pulmonary embolus. In: Clark SL, Phelan JP, Cotton DB, eds. Critical Care Obstetrics. Oradell: Medical Economics Books, 1987:126-151.
28. Kearon C, Hirsh J. Factors influencing the reported sensitivity and specificity of impedance plethysmography for proximal deep vein thrombosis. Thromb Haemost. 1994;72:652-658.
29. Ginsberg JS, Wells PS, Hirsh J, Panju AA, Patel MA, Malone DE, McGinnis J, Stevens P, Brill-Edwards P. Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. Arch Intern Med. 1994;154: 1930-1933.
30. Laros RK. Thromboembolic disease. In: Creasy RK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice. Philadelphis: WB Saunders, 1994:792-803.
31. Keogan MT, Paulson ED, Paine SS, Hertzberg BS, Carroll BA. Bilateral lower extremity evaluation of deep venous thrombosis with color flow and compression sonography. J Ultrasound Med. 1994;13:115-118.
32. Heijboer H, Buller HR, Lensing AW, Turpie AG, Colly LP, ten Cate JW. A comparison of real-time compression ultrosonography with impedance plethysmography for the diagnosis of deep vein thrombosis in symptomatic outpatients. N Engl J Med. 1993;329:1365-1369.
33. Cowchock SF, Merli GJ. Pulmonary embolism and thrombophlebitic disorders. In: Gleicher N, ed. Principles and Practice of Medical Therapy in Pregnancy. Norwalk; Appleton and Lange, 1992:739-743.
34. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost. 1994;71:1-6.
35. Spritzer CE, Evans AC, Kay JJ. Magnetic resonance imaging of deep venous thrombosis in pregnant women with lower extremity edema. Obstet Gynecol. 1995;85: 603-607.
36. Rutherford SE, Phelan JP. Deep venous thrombosis and pulmonary embolism in pregnancy. Obstet Gynecol Clin North Am. 1991;18:345-370.
37. The PIOPED Investigators: value of the venitlation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;273:2753-2759.
38. Matsumoto AH, Tegtmeyer CJ. Contemporary diagnostic approaches to acute pulmonary emboli. Radiol Clin North Am. 1995;33:167-183.
39. Kearon C, Hirsh J. The diagnosis of pulmonary embolism. Haemostasis. 1995;25: 72-87.
40. Greenspan RH. Pulmonary angiography and the diagnosis of pulmonary embolism. Prog Cardiovasc Dis. 1994;37:93-105.
41. Remy-Jardin M, Remy J, Wattinne, et al. Central pulmonry thromboembolism diagnosis with spiral volumetric CT with the single-breath-hold technique: comparison with pulmonary angiography. Radiology. 1992;185:381-387.
42. Goldhaber SZ. Venous thrombosis: prevention, treatment and relationship to paradoxical embolization. Cardiology Clinics. 1994;12:505-516.
43. Hirsh J, Levine MN. Low molecular weight heparin. Blood. 1992;79:1-17.
44. White TM, Bernene JL, Marino AM. Continuous heparin infusion requirement: diagnostic and therapeutic implications. JAMA. 1979;241:2717-2720.
45. DeSwart CAM, Nijmeter B, Roelofs JMM, et al. Kinetics of intravenously administered heparin in normal humans. Blood. 1982;60: 1251-1258.
46. Perry PJ, Herron GR, King JC. heparin half-life in normal and impaired renal function. Clin Pharmacol Res. 1974;16:514-519.
47. Levine MN, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med. 1991;114:545-551.
48. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1978;68:122-140.
49. Walker, AM, Jick H. Predictors of bleeding during heparin therapy. JAMA. 1980;244: 1209-1212.
50. Chang BH, Pitney WR, Castaldi PA. Heparin induced thrombocytopenia. Lancet. 1982;2:1246-1249.
51. de Swiet M, Dorrington-Ward P, Fidler J, et al. Prolonged heparin therapy in pregnancy causes bone demineralization (heparin induced osteopenia). Br J Obstet Gynaecol. 1983;90:1129-1134.
52. Anderson G, Fagrell B, Holmgren K, et al. Subcutaneous administration of heparin: a randomized comparison with intravenous administration of heparin to patients with deep vein thrombosis. Thromb Res. 1982: 27:631-639.
53. Bentley PG, Kakkar VV, Scully MF, et al. An objective study of the alternate methods of heparin administration. Thromb Res. 1980;18:177-187.
54. Barss VA, Schwartz PA, Green MF, et al. Use of the subcutaneous heparin pump during pregnancy. J Reprod Med. 1985;30:899-901.
55. Nelson DM, Stempel LE, Fabri PJ, et al. Hickman catheter use in a pregnant patient requiring therapeutic heparin anticoagulation. Am J Obstet Gynecol. 1984;149:461-462.
56. Alleman BH, Gerber H, Gruber UF. Ruchkenmarksnahe Anaesthesie und subkutan verabreichtes low-dose Heparin-Dihydergot zur thromboprophylaxie. Anaesthetist. 1983;32:80-83.
57. Fredin HO, Rosberg B, Arborelius M, Nylander G. On thromboembolism after total hip replacement in epidural analgesia: a controlled study of dextran 70 and low-dose heparin combined with dihydroegrotamine. Br J Surg. 1984;71:58-60.
58. Becker MH, Genieser, NB, Fengold M. Chondrodysplasia punctata; is maternal warfarin therapy a factor? Am J Dis Child. 1975;129:356-359.
59. Iturbe-Alessiol, del Carmen Fonseca M, Mutchinik O, et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med. 1986;315:390-393.
60. Greaves M. Anticoagulants in pregnancy. Pharmac Ther. 1993;59:311-327.
61. McKenna R, Cole ER, Vasan U. Is warfarin sodium contraindicated in the lactating mother? Pediatrics. 1983;103:325-327.
62. Hux CH, Wapner RJ, Chayen B, et al. use of the Greenfield filter for thromboembolic disease in pregnancy. Am J Obstet Gynecol. 1986;155:734-737.
63. Aburahma AF, Bastug HF, Tiley HH, Killmer SM, Boland JP. Management of deep vein thrombosis of the lower extremity in pregnancy. W V Med J. 1993;89:445-447.
64. Narayan H, Cullimore J, Krarup K, Thurston H, Macvicar J, Bolia A. Experience with the Cardial inferior vena cava filter as prophylaxis against pulmonary embolism in pregnant women with extensive deep venous thrombosis. Br J Obstet Gynecol. 1992;99: 637-640.
65. Delclos GL, Davila F. Thrombolytic therapy for pulmonary embolisn in pregnancy: a case report. Am J Obstet Gynecol. 1986;155; 375-376.
66. Richards SR, Barrow H, O'Shaughnessy R. Intrapartum pulmonary embolus. J Reprod Med. 1985;30:64-66.
67. Howell R, Fidler J, Letsky E, et al. The risks of antenatal subcutaneous heparin prophylaxis: a controlled trial. Br J Obstet Gynaecol. 1983;90:1124-1128.
68. Lao TT, Deswiet M, Letsky E, et al. Prophylaxis of thromboembolism in pregnancy: an alternative. Br J Obstet Gynaecol. 1985;92:202-206.
69. Dahlman TC, Hellgren SE, Blombac M. Thrombosis prophylaxis in pregnancy with use of subcutaneious heparin adjusted by monitoring heparin concentration in plasma. Am J Obstet Gynecol. 1989;161;420-425.
70. Tengborn L, Bergqvist D, Matzsch T, et al. Recurrent thromboembolism in pregnancy and puerperium: is there a need for thromboprophylaxis? Am J Obstet Gynecol. 1989;160:90-94.